The short answer: tesamorelin is best for reducing visceral (belly) fat and improving metabolic markers, while sermorelin is better for anti-aging, sleep, recovery, and overall wellness
or a pharmacy name you cannot verify
Lifestyle support, nutritional guidance, and metabolic monitoring make long term success much more achievable
The study achieved an unprecedented 90% accuracy in distinguishing individuals with ME/CFS based entirely on these biological markers, definitively proving that gut dysbiosis is a core driver of the disease, not just a secondary symptom
As evaluated by MR scans, the sub-study showed all three doses of tirzepatide (5 mg, 10 mg, 15 mg) led to greater reductions in liver fat content compared to insulin degludec, and reductions in volume of visceral adipose tissue and abdominal subcutaneous adipose tissue compared to increases in volume of both measurements with insulin degludec at 52 weeks